p53: Tumor suppression through control of the cell cycle
Open Access
- 1 June 1994
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 106 (6), 1708-1711
- https://doi.org/10.1016/0016-5085(94)90431-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Spontaneous mutation rates in cloned murine tumors do not correlate with metastatic potential, whereas the prevalence of karyotypic abnormalities in the parental tumors doesInternational Journal of Cancer, 1987